UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in Select Medical Holdings Co. (NYSE:SEM)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 18.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 313,639 shares of the health services provider's stock after purchasing an additional 49,281 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.24% of Select Medical worth $5,912,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Smartleaf Asset Management LLC increased its position in Select Medical by 179.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock worth $43,000 after acquiring an additional 1,473 shares during the period. Covestor Ltd increased its holdings in shares of Select Medical by 33.5% during the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock worth $93,000 after purchasing an additional 1,244 shares during the period. Lazard Asset Management LLC raised its position in shares of Select Medical by 47.8% in the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock valued at $130,000 after buying an additional 2,255 shares in the last quarter. Quarry LP boosted its stake in shares of Select Medical by 963.0% in the fourth quarter. Quarry LP now owns 9,078 shares of the health services provider's stock valued at $171,000 after buying an additional 8,224 shares during the period. Finally, HBK Investments L P bought a new position in Select Medical during the 4th quarter worth $188,000. 89.48% of the stock is owned by institutional investors.

Select Medical Trading Up 0.4%

NYSE:SEM traded up $0.07 during mid-day trading on Thursday, hitting $15.31. 391,676 shares of the company's stock were exchanged, compared to its average volume of 932,075. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical Holdings Co. has a fifty-two week low of $14.03 and a fifty-two week high of $40.98. The company has a 50 day simple moving average of $15.84 and a 200-day simple moving average of $18.61. The firm has a market capitalization of $1.97 billion, a P/E ratio of 9.26, a PEG ratio of 0.64 and a beta of 1.34.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing analysts' consensus estimates of $0.45 by ($0.01). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same period in the prior year, the firm earned $0.75 earnings per share. Select Medical's revenue was down 24.4% compared to the same quarter last year. As a group, research analysts expect that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th were issued a dividend of $0.0625 per share. The ex-dividend date was Thursday, May 15th. This represents a $0.25 annualized dividend and a dividend yield of 1.63%. Select Medical's dividend payout ratio is currently 18.66%.

Select Medical declared that its Board of Directors has authorized a stock repurchase plan on Thursday, May 1st that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the health services provider to repurchase up to 42.6% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its shares are undervalued.

Analyst Ratings Changes

A number of brokerages recently commented on SEM. Royal Bank of Canada decreased their price target on Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 7th. Mizuho started coverage on Select Medical in a report on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price target for the company. Wall Street Zen upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a research report on Friday, February 21st. Finally, Benchmark upgraded shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price on the stock in a research report on Monday, February 24th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Select Medical has an average rating of "Moderate Buy" and a consensus price target of $26.00.

Insider Buying and Selling

In other Select Medical news, CEO David S. Chernow sold 225,000 shares of Select Medical stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the completion of the transaction, the chief executive officer now owns 714,516 shares in the company, valued at approximately $12,861,288. The trade was a 23.95% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Parvinderjit S. Khanuja acquired 21,000 shares of the stock in a transaction dated Monday, May 5th. The stock was bought at an average cost of $15.02 per share, with a total value of $315,420.00. Following the completion of the purchase, the director now owns 65,089 shares of the company's stock, valued at approximately $977,636.78. The trade was a 47.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. 11.60% of the stock is owned by company insiders.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.